Update on herpesvirus infections

Dental Clinics of North America

Volumn 47, Issue 3, 2003, Pages 517-532

  Stoopler, Eric T ^a   Greenberg, Martin S ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CAPSAICIN; GABAPENTIN; TRICYCLIC ANTIDEPRESSANT AGENT; VIRUS ANTIGEN;

ANTIBODY TITER; ANTIGEN DETECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DERMATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; EPSTEIN BARR VIRUS; FLUORESCENT ANTIBODY TECHNIQUE; HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HOST PATHOGEN INTERACTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; IMPRESSION CYTOLOGY; MENINGOENCEPHALITIS; MOUTH INFECTION; PHARYNGITIS; POSTHERPETIC NEURALGIA; PRIMARY INFECTION; RECURRENT INFECTION; REVIEW; SEROLOGY; SEXUAL TRANSMISSION; VARICELLA ZOSTER VIRUS; VIROLOGY; VIRUS IDENTIFICATION; VIRUS ISOLATION; DENTAL CARE; HERPES VIRUS; HERPES VIRUS INFECTION; IMMUNE DEFICIENCY; MOUTH DISEASE; PATHOLOGY; RECURRENT DISEASE;

DENTAL CARE FOR CHRONICALLY ILL; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MOUTH DISEASES; RECURRENCE;

EID: 0042011621     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-8532(03)00018-1     Document Type: Review

References (61)

1. Greenberg M.S. Herpesvirus infections. Dent Clin N Am. 40:(2):1996;359-368
2. Ronit S., Klepfish A., Schattner A. Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo Clin Proc. 77:(9):2002;941-949
3. Rickinson A. Epstein-Barr virus. Virus Res. 82:(1-2):2001;109-113
4. Greenberg M.S. Ulcerative, vesicular, and bullous lesions. Greenberg M.S., Glick M. Burket's oral medicine: diagnosis and treatment. 10th edition:2003;50-84 BC Decker, Ontario
5. MacPhail L., Greenspan D. Herpetic gingivostomatitis in a 70 year old man. Oral Surg Oral Med Oral Pathol. 79:(1):1995;50-52
6. Penna J.J., Eskinazi D.P. Treatment of oro-facial herpes simplex infections with acyclovir: a review. Oral Surg Oral Med Oral Path. 65:1988;689-692
7. Amir J., Harel L., Smetana Z., Varsano I. Treatment of herpes simplex gingivostomatitis with acyclovir in children: a randomized double blind placebo controlled study. BMJ. 314:1997;1800-1803
8. Balfour H.H. Antiviral drugs. N Engl J Med. 340:1999;1255-1268
9. Regezi J.A., Sciubba J. Vesiculo-bullous diseases. Regezi J.A., Sciubba J. Oral pathology: clinical-pathological correlations. 2nd edition:1993;1-33 WB Saunders, Philadelphia
10. Straten M.V., Carrasco D., Lee P., Tyring S. A review of antiviral therapy for herpes labialis. Arch Dermatol. 137:2001;1232-1235
11. McKeough M., Spruance S. Comparison of new topical treatments for herpes labialis. Arch Dermatol. 137:2001;1153-1158
12. Spruance S.L., Rea T.L., Thoming C., Tucker R., et al. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA. 277:1997;1374-1379
13. Greenberg M.S., Friedman H., Cohen S.G., et al. A comparative study of herpes simplex infections in renal transplant and leukemic patients. J Infect Dis. 156:(2):1987;280-287
14. Redding S.W., Montgomery M.T. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants. Oral Surg Oral Med Oral Path. 67:(6):1989;680-683
15. Macphael L.A., Greenspan D., Schiodt M., Drennan D.P., Mills J. Acyclovir resistant foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS. Oral Surg Oral Med Oral Path. 67:(4):1989;427-432
16. Gleaves C.A., Hodinka R.L., Johnston S.L., Swierkosz E.M. Laboratory diagnosis of viral infections. Cumitech 15A. 1994;American Society for Microbiology, Washington, DC
17. Meyer M.P., Amortegui H.J. Rapid detection of herpes simplex virus using a combination of human fibroblast cell culture and peroxidase-antiperoxidase staining. Am J Clin Pathol. 81:(1):1984;43-47
18. Linde A. The importance of specific virus diagnosis and monitoring for antiviral treatment. Antiviral Res. 51:(2):2001;81-94
19. Cohen P.R. Tests for detecting herpes simplex virus and varicella-zoster virus infections. Derm Clinics. 12:(1):1994;51-66
20. Erlich K.S. Laboratory diagnosis of herpesvirus infections. Clin Lab Med. 7:(4):1987;759-776
21. Chan E.L., Brandt K., Horsman G.B. Comparison of chemicon simulfluor direct fluorescent antibody staining with cell culture and shell vial direct immunoperoxidase staining for detection of herpes simplex virus and with cytospin direct immunofluoresence staining for detection of varicella-zoster virus. Clin Diag Lab Immunol. 8:(5):2001;909-912
22. Sanders C., Nelson C., Hove M., Woods G.L. Cytospin-enhanced direct immunofluorescence assay versus cell culture for detection of herpes simplex virus in clinical specimens. Diag Micro Infect Disease. 32:(2):1998;111-113
23. Linnemann C.C., Shea L., Partin J.C., et al. Reye's syndrome: epidemiology and viral studies, 1963-1974. Am J Epidemiol. 101:(6):1975;517-526
24. Dwyer D.E., Cunningham A.L. Herpes simplex and varicella-zoster virus infections. Med J Aust. 177:2002;267-273
25. Sissons J.G.P., Carmichael A.J. Clinical aspects and management of cytomegalovirus infections. J Infect. 44:2002;78-83
26. Ramsay M.E., Miller E., Peckham C.S. Outcome of confirmed symptomatic congenital cytomegalovirus infection. Arch Dis Child. 66:(9):1991;1068-1069
27. Grisius M.M., Fox P.C. Salivary gland disease. Greenberg M.S., Glick M. Burket's oral medicine: diagnosis and treatment. 10th edition:2003;235-270 BC Decker, Ontario
28. Jacobsen M.A. Treatment of cytomegalovirus retinitis in patients with the acquired immune deficiency syndrome. N Engl J Med. 337:(2):1997;105-114
29. Karavellas M.P., Plummer D.J., Macdonald J.C., Torriani F.J., Shufelt C.L., Azen S.P., et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institiution of successful highly active antiretroviral therapy. J Infect Dis. 179:(3):1999;697-700
30. Flaitz C.M., Nichols M.C., Hicks J.M. Herpesviridae-associated persistent mucocutaneous ulcers in acquired immunodeficiency syndrome: a clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 81:(4):1996;433-441
31. Regezi J.A., Eversole R.L., Barker B.F., Rick G.M., Silvereman S. Herpes simplex and cytomegalovirus coinfected oral ulcers in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 81:(1):1996;55-62
32. Slots J., Contreras A. Herpesviruses: a unifying causative factor in periodontitis? Oral Microbiol Immunol. 15:(5):2000;277-280
33. Greenberg M.S., Dubin G., Stewart J.C.B., Cumming C.G., MacGregor R.R., Friedman H.M. Relationship of oral disease to the presence of cytomegalovirus DNA in the saliva of AIDS patients. Oral Surg Oral Med Oral Pathol. 79:(2):1995;175-179
34. Greenberg M.S., Glick M., Nghiem L., Stewart J.C.B., Hodinka R., Dubin G. Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 83:(3):1997;334-339
35. Emery V.C., Hassan-Walker A.F. Focus on new drugs in development against human cytomegalovirus. Drugs. 62:(13):2002;1853-1858
36. Cohen J.I. Epstein-Barr virus infection. N Engl J Med. 343:(7):2000;481-492
37. Henke C.E., Kurland L.T., Elveback L.R. Infectious mononucleosis in Rochester, Minnesota, 1950 through 1969. Am J Epidemiol. 98:(6):1973;483-490
38. Straus S.E., Cohen J.I., Tosato G., Meier J. NIH conference: Epstein-barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 118:(1):1993;45-58
39. Straus S.E. The chronic mononucleosis syndrome. J Infect Dis. 157:(3):1988;405-412
40. Salahuddin S.Z., Ablashi D.V., Markham P.D., Josephs S.F., Sturzenegger S., Kaplan M., et al. Isolation of a new virus HBLV in patients with lymphoproliferative disorders. Science. 234:(4776):1986;596-601
41. Lusso P., Markham P.D., Tschachler E., di Marzo Veronese F., Salahuddin S.Z., Ablashi D.V., et al. In vitro cellular tropism of human B-lymphotropic virus (human herpes virus 6). J Exp Med. 167:(5):1988;1659-1670
42. Takahashi K., Sonoda S., Higashi K., Kondo T., Takahashi H., Takahashi M., et al. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol. 63:(7):1989;3161-3163
43. Blauvet A. Skin diseases associated with human herpesvirus 6, 7, and 8 infection. J Invest Dermatol Symp Proceed. 6:2001;197-202
44. Schirmer E.C., Wyatt L.S., Yamanishi K., Rodriguez W.J., Frenkel N. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci USA. 88:(13):1991;5922-5926
45. Lusso P., Gallo R.C. Human herpesvirus 6 in AIDS. Immunol Today. 16:(2):1995;67-71
46. Suzuki Y., Inagi R., Aono T., Yamanishi K., Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug induced hypersensitivity syndrome. Arch Dermatol. 134:(9):1998;1108-1112
47. Tohyama M., Yahata Y., Yasukawa M., Inagi R., Urano Y., Yamanishi K., et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol. 134:(9):1998;1113-1117
48. Wyatt L.S., Rodriguez W.J., Balachandran N., Frenkel N. Human herpesvirus 7: antigenic properties and prevalence in children and adults. J Virol. 65:(11):1991;6260-6265
49. Kastafanas G.C., Schirmer E.C., Wyatt L.S., Frenkel N. In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci USA. 93:1996;9788-9792
50. Tanaka-Taya K., Kondo T., Nakagawa N., Inagi R., Miyoshi H., Sunagawa T., et al. Reactivation of human herpesvirus 6 by infection of human herpesvirus 7. J Med Virol. 60:(3):2000;284-289
51. Sarid R., Klepfish A., Schattner A. Virology, pathogenic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (Human Herpesvirus 8). Mayo Clin Proc. 77:(9):2002;941-949
52. Schulz T.F. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res. 76:1999;121-160
53. Oksenhendler E., Cazals-Hatem D., Schulz T.F., Barateau V., Grollet L., Sheldon J., et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med. 338:(22):1998;1585-1590
54. Luppi M., Barozzi P., Schulz T.F., Setti G., Staskus K., Trovato R., et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med. 343:(19):2000;1378-1385
55. Martin J.N., Ganem D.E., Osmond D.H., Page-Shafer K.A., Macrae D., Kedes D.H. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 338:(14):1998;948-954
56. Blackbourne D.J., Ambroziak J., Lennette E., Adams M., Ramachandran B., Levy J.A. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet. 349:(9052):1997;609-611
57. Cannon M.J., Dollard S.C., Smith D.K., Klein R.S., Schuman P., Rich J.D., et al. HIV Epidemiology Research Study Group. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med. 344:(9):2001;637-643
58. Molinari J.A., Glick M. Infectious diseases. Greenberg M.S., Glick M. Burket's oral medicine: diagnosis and treatment. 10th edition:2003;525-562 BC Decker, Ontario
59. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 86:(4):1995;1276-1280
60. Grandadam M., Dupin N., Calvez V., Gorin I., Blum L., Kernbaum S., et al. Exacerbations of clinical symptoms in human immunodeficiency virus type-1 infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis. 175:(5):1997;1198-1201
61. Katano H., Suda T., Morishita Y., Yamamoto K., Hoshino Y., Nakamura K., et al. Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology. Mod Pathol. 13:(1):2000;77-85